Next-Generation Sequencing Based MiseqDx Extended RAS panel for FFPE Colorectal Samples

被引：0
|
作者：
Iyer, A. [1 ]
Haigis, R. [1 ]
Porter, M. [1 ]
Fabian, J. [1 ]
Gros, T. [1 ]
Hasnat, F. [1 ]
Dunn, T. [1 ]
Saad, W. [1 ]
Lin, E. [1 ]
Ong, F. [1 ]
Harris, M. [1 ]
Udar, N. [1 ]
机构：
[1] Illumina, San Diego, CA USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2014年 / 16卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
ST111
引用
收藏
页码：771 / 771
页数：1
相关论文
共 50 条
  • [1] Highly sensitive and multiplexed next-generation sequencing MiSeqDx Extended RAS Panel for FFPE colorectal samples
    Udar, N.
    Porter, M.
    Haigis, R.
    Fabian, J.
    Dunn, T.
    Lee, D.
    Lee, D.
    Gros, T.
    Hasnat, F.
    Lofton-Day, C.
    Jung, S.
    Iyer, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S134 - S134
  • [2] Validation of a Next-Generation Sequencing-Based Assay to Detect Extended RAS Mutations in FFPE Samples for Identification of Metastatic Colorectal Cancer Patients Eligible for Treatment with Panitumumab
    Udar, N.
    Lofton-Day, C.
    Dong, J.
    Vavrek, D.
    Meier, K.
    Jung, A.
    Iyer, A.
    Peeters, M.
    Douillard, J.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1056 - 1056
  • [3] Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME study
    Udar, Nitin
    Lofton-Day, Catherine
    Dong, Jun
    Vavrek, Darcy
    Jung, A. Scott
    Meier, Kristen
    Iyer, Anita
    Slaughter, Ryan
    Gutekunst, Karen
    Bach, Bruce A.
    Peeters, Marc
    Douillard, Jean-Yves
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (10) : 2001 - 2010
  • [4] Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME study
    Nitin Udar
    Catherine Lofton-Day
    Jun Dong
    Darcy Vavrek
    A. Scott Jung
    Kristen Meier
    Anita Iyer
    Ryan Slaughter
    Karen Gutekunst
    Bruce A. Bach
    Marc Peeters
    Jean-Yves Douillard
    [J]. Journal of Cancer Research and Clinical Oncology, 2018, 144 : 2001 - 2010
  • [5] A rapid, multiplexed, and highly accurate next -generation sequencing RAS Panel for FFPE colorectal samples reporting on the absence or presence of low frequency somatic variants
    Dunn, Tamsen
    Iyer, Anita
    Porter, Margaret
    Haigis, Robert
    Smith, Shannon
    Lee, Desiree
    Udar, Nitin
    [J]. CANCER RESEARCH, 2016, 76
  • [6] Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing
    Sakai, Kazuko
    Tsurutani, Junji
    Yamanaka, Takeharu
    Yoneshige, Azusa
    Ito, Akihiko
    Togashi, Yosuke
    De Velasco, Marco A.
    Terashima, Masato
    Fujita, Yoshihiko
    Tomida, Shuta
    Tamura, Takao
    Nakagawa, Kazuhiko
    Nishio, Kazuto
    [J]. PLOS ONE, 2015, 10 (05):
  • [7] Optimized Sample and Library Preparation of FFPE Tumor Samples for Targeted Next-Generation Sequencing
    Nitin, U.
    Haigis, R.
    Jaeger, E. B.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 720 - 721
  • [8] A novel, statistical-based method to determine RNA expression by next-generation sequencing in clinical FFPE samples
    Shoemaker, Robert
    Berlin, Aaron
    Diliberto, Amy
    Ely, Heather
    Chen, Marissa
    Murphy, Danielle
    Christiansen, Jason
    Reuter, Vince
    Licon, Abel
    [J]. CANCER RESEARCH, 2016, 76
  • [9] A next-generation sequencing assay to estimate tumour mutation burden from FFPE research samples
    Chaudhary, R.
    Cyanam, D.
    Sadis, S.
    Bishop, J.
    Allen, C.
    Hyland, F.
    Gilmour, K.
    [J]. VIRCHOWS ARCHIV, 2017, 471 : S41 - S41
  • [10] Microsatellite instability assessment of FFPE tumor samples through targeted next-generation sequencing.
    Wong-Ho, Elaine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345